Transcode Therapeutics Inc
NASDAQ:RNAZ
Transcode Therapeutics Inc
NASDAQ:RNAZ
Price:
1.775 USD
8.23%
Market Closed
Updated:
Jun 1, 2024
Transcode Therapeutics Inc
Common Shares Outstanding
|
Transcode Therapeutics Inc
Common Shares Outstanding Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Transcode Therapeutics Inc
NASDAQ:RNAZ
|
Common Shares Outstanding
$627k
|
CAGR 3-Years
285%
|
CAGR 5-Years
124%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Transcode Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
627k
USD
627k
USD
Based on the financial report for Dec 31, 2023, Transcode Therapeutics Inc's Common Shares Outstanding amounts to 627k USD.
What is Transcode Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
124%
124%
Over the last year, the Common Shares Outstanding growth was 3 819%. The average annual Common Shares Outstanding growth rates for Transcode Therapeutics Inc have been 285% over the past three years , 124% over the past five years .
You don't have any saved screeners yet
